ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000246.1|Mithramycin_1 # 126 # 1193 # 1 # ID=1_1;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.683	BGC0000246.1|Mithramycin_1 	126	1193	+	Loose	450	25.409	ANT(4')-Ib	55.56	3003905	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(4')	ATGAAGGCACTCGTTCTGTCCGGTGGCTCGGGCACACGCCTGAGGCCCATCACCCACACATCGCCCAAGCAGCTGGTGCCGGTGGCGAACAAACCTGTTCTCTTCTACGCCCTGGAGGACATCGCGCAGGCCGGGATCACCGACGTCGGGATCGTCGTCGGTGAGACGGCCCGCGAGATCGAGGACGCGGTGGGCGACGGTTCCAAGTTCGGCCTCCAGGTGACCTACCTGCCGCAGGAGAAACCCCTGGGACTCGCCCACGCGGTCCTGATCGCCCGCGACTACCTCGGTGACGACGACTTCGTCATGTACCTGGGAGACAACTTCGTGGTCGGCGGCATCGCCGGTCTGGTGGACGAGTTCCGTGCGGACCGGCCCGACGCGCGGATCCTGCTGACCCCCGTTCCCGATCCGACGGCCTTCGGCATCGCCGAGCTGGACGGGGAGGGCCGGGTCGTACGCCTGGAGGAGAAGCCGACGCACCCCAAGAGCGACATGGCGGTGATCGGCGTCTACCTGTTCACCCCGCTCGTGCACGAGGCCGTGCGCGCCATCGAGCCGTCGTGGCGGGGGGAGCTGGAAATCACCCATGCCATCCAGTGGCTCATCGACAACCGCCACGACGTGCGGTCTACCGTGATCCACGGCTACTGGAAGGACACCGGCAACGTCATGGACATGCTGGAGGTCAACCGGACGGTGCTGGAGGGCGTCGAGCCGTGCACCGAGGGCCCGGTCGACGCGGAGAGCGAGGTGATCGGCCGCGTCAGGATCGAGGCCGGCGCCCGGGTCAGCAATTCGCGGATCGTCGGTCCCGCGGTGATCGGGTCGGGCACGGTGATCAGCGGTTCCTACATCGGGCCGTACACGTCCGTCTCCGAGGGCTGCCGGATCGAGGACAGCGAGATCGAGTTCTCGATCGTGCTGCGCGACTCACGGGTGCGGGGCGTCCAGCGGGTCAGGGGGTCCCTCATCGGCCGCAGTGTCACCGTGGCCCCCGCCCCCCGCAAGCCGGCCGGCACCCGGCTCGTTCTCGGCGACCACAGCGAGGGGCAGATCTCCTCATGA	MKALVLSGGSGTRLRPITHTSPKQLVPVANKPVLFYALEDIAQAGITDVGIVVGETAREIEDAVGDGSKFGLQVTYLPQEKPLGLAHAVLIARDYLGDDDFVMYLGDNFVVGGIAGLVDEFRADRPDARILLTPVPDPTAFGIAELDGEGRVVRLEEKPTHPKSDMAVIGVYLFTPLVHEAVRAIEPSWRGELEITHAIQWLIDNRHDVRSTVIHGYWKDTGNVMDMLEVNRTVLEGVEPCTEGPVDAESEVIGRVRIEAGARVSNSRIVGPAVIGSGTVISGSYIGPYTSVSEGCRIEDSEIEFSIVLRDSRVRGVQRVRGSLIGRSVTVAPAPRKPAGTRLVLGDHSEGQISS	MNMNGPASMAQKERLQTCQEIAKRLHEVYGNDVLAIGVYGSVSRGTDGPFSDIEMFCVLRDSAETVDKSYEWSAGPWKAEVNVCSASILLKDAATVEDRWPLTHGPYFSPLRLYDPEGFFQRLRLAAESPTKEDFRQAIHEILVGEMYEYVGKLRNVNRNGPSTYLPSLALRFAHYGAMLIGLHNQTLFSTGAMVLPEALKLPHRPKGFDHVAELAMSGDLAQPAKIVSACEDFWKGLVAWAAEHDYVIHSKRIPF	138.67	gnl|BL_ORD_ID|2143|hsp_num:0	2383			105	186	dibekacin; amikacin; tobramycin; isepamicin
BGC0000246.1|Mithramycin_2 # 1190 # 2185 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=3Base/5BMM;rbs_spacer=13-15bp;gc_cont=0.692	BGC0000246.1|Mithramycin_2 	1190	2185	+	Loose	1200	37.3502	arnA	23.01	3002985	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGACCACCACATCCATCCTGGTGACGGGCGGGGCCGGCTTCATCGGCTCGCACTACGTGCGGACCCTGCTCGGTCCGCGCGGCGTGCCGGACGTGACGGTCACCGTGCTCGACAAGCTGACGTACGCCGGGACCCTCACCAACCTCGCCGAGGTGAGCGACAGCGACCGGTTCCGGTTCGTCCGGGGCGACATCTGCGACGCACCCCTGGTCGACGACCTGCTCGCAGTGCACGACCAAGTGGTGCACTTCGCCGCCGAGTCGCACGTCGACCGGTCCATTCTGGGCGCCGCCGACTTCGTACGCACCAATGTCACCGGTACCCAGACGCTCCTCGACGCGGCGCTGCGGCAGGGGATCGAGACGTTCGTGCACATCTCCACCGACGAGGTGTACGGCTCCATCGACGCCGGGTCCTGGCCGGAGACGGCGCCGGTCAGCCCCAACTCGCTCTATTCCGCAGCCAAGGCGTCCAGCGATCTCGTGGCGCTGGCCTACCACCGCACCCACGGTCTGGACGTGCGGGTCACGCGTTGCTCGAACAACTACGGGTCCCATCAGTTCCCGGAGAAGGTCATCCCGCTGTTCGTCACCAGTCTGCTCGACGGCCGCGAGGTGCCGTTGTACGGGGACGGCACCAACGTACGCGACTGGCTGCACGTCGACGACCACGTCCGCGCGATCGAGCTGGTCCGCACGGGAGGTCGGGCCGGCGAGGTCTACAACATCGGCGGCGGCACCGAGCTGTCCAACAAGGAGCTGACGCAGCTGCTCCTGGACGCCTGTGGCGCCGGCTGGGACCGCGTGCGGTACGTCACCGACCGCAAGGGGCACGACCGGCGCTACTCCGTCGACTGCACGAAGATCCGGCGTGAGCTCGGGTACCGGCCGGCTCGGGAGTTCGGGGACGCACTGGCCGAGACTGTCGCCTGGTACCGCCACCACCGTGCCTGGTGGGAGCCGCTGACGCGGGCGTACGGGGCGGTGGCGGCCTGA	MTTTSILVTGGAGFIGSHYVRTLLGPRGVPDVTVTVLDKLTYAGTLTNLAEVSDSDRFRFVRGDICDAPLVDDLLAVHDQVVHFAAESHVDRSILGAADFVRTNVTGTQTLLDAALRQGIETFVHISTDEVYGSIDAGSWPETAPVSPNSLYSAAKASSDLVALAYHRTHGLDVRVTRCSNNYGSHQFPEKVIPLFVTSLLDGREVPLYGDGTNVRDWLHVDDHVRAIELVRTGGRAGEVYNIGGGTELSNKELTQLLLDACGAGWDRVRYVTDRKGHDRRYSVDCTKIRRELGYRPAREFGDALAETVAWYRHHRAWWEPLTRAYGAVAA	MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA	50.00	gnl|BL_ORD_ID|1513|hsp_num:0	1643			951	1959	polymyxin B
BGC0000246.1|Mithramycin_3 # 2185 # 2388 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GGxGG;rbs_spacer=5-10bp;gc_cont=0.760	BGC0000246.1|Mithramycin_3 	2185	2388	+	Loose	750	21.557	patA	36.36	3000024	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGGGCGGTGTGCTGCGCGGTGTGTGGGAGAGCCTGGTCCGCCTCGGCGCGCTGCACGTCGGCGTCGTGCACCACGAGGAGGCGCAGGTCCTCGCGGCCCTCGGTCAGGTGGGCTGCTTCCTGACCGGCGTGACGGCGAGCCGTGGCCGACCACCGGAGGAGCCGGCGCCGGGAGAACCGCGGGACGGCCGCCGCCACGGCTGA	MGGVLRGVWESLVRLGALHVGVVHHEEAQVLAALGQVGCFLTGVTASRGRPPEEPAPGEPRDGRRHG	MLIQKIKTYKWQALASLLMTGLMVASSLLQPRYLQEVLGALLTGKYEAIYSIGAWLIGVAVVGLVAGGLNVVLAAYIAQGVSSDLREDAFRKIQTFSYADIEQFNAGNLVVRMTNDINQIQNVVMMTFQILFRLPLLFIGSFILAVQTLPSLWWVIVLMVVLIFGLTAVMMGMMGPRFAKFQTLLERINAIAKENLRGVRVVKSFVQEKEQFAKFTEVSDELLGQNLYIGYAFSVVEPFMMLVGYGAVFLSIWLVAGMVQSDPSVVGSIASFVNYLSQIIFTIVMVGFLGNSVSRAMISMRRIREILDAEPAMTFKDIPDEELVGSLSFENVTFTYPMDKEPMLKDVSFTIEPGQMVGVVGATGAGKSTLAQLIPRLFDPQDGAIKIGGKDIREVSEGTLRKTVSIVLQRAILFSGTIADNLRQGKGNATLFEMERAANIAQASEFIHRMEKTFESPVEERGTNFSGGQKQRMSIARGIVSNPRILIFDDSTSALDAKSERLVQEALNKDLKGTTTIIIAQKISSVVHADKILVLNQGRLIGQGTHADLVANNAVYREIYETQK	11.88	gnl|BL_ORD_ID|1907|hsp_num:0	2081			111	177	ciprofloxacin; norfloxacin
BGC0000246.1|Mithramycin_4 # 2604 # 3365 # -1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=AGGA/GGAG/GAGG;rbs_spacer=11-12bp;gc_cont=0.744	BGC0000246.1|Mithramycin_4 	2604	3365	-	Loose	500	28.4906	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid	22.89	3003393	protein variant model	S94A	n/a	isoniazid-like antibiotic	antibiotic target alteration	isoniazid resistant inhA	ATGGACATGGGACTGACAGGCCGCAGGGTGCTCGTCACGGGCGGGTCCTCCGGAATCGGTGCGGCCGTCGCGCGCGCCTACGCGGACGAGGGGGCGCGGGTCGCCCTCACCTACCGCGGCGGCGACGAGGCGGCCGAACGGCTCGCCCGTGAACTCGGCGCGGGCCGGCACGCGGCAATGGCGGTGCGGTACTCCCTCGGGGAGCCGGACACCGTGGAGTCGGCCGTCGCCACGGTGACCGAACGCTGGGGCGGGGTGGACGTGCTCGTCGCGAACGCGGTGCGCTGGGCTCCCCGCCGGGCGCCCGGCACCCGGTTCGAGGAGGTCGCGTCCGGGGACTGGCGGGGTTTCCTCGACGACAACCTGGCGCCGACCCTGCGTACCGTGCAGCTGGTGGTGGCCGGGATGCGGGCGCGGTCCTGGGGCAGGATCGTGCTCATCTCCTCGCATGTGGCCCTCGACGGCCACCGCGGGCAGGAGTTCTACGGCGCCGCCAAGTCGGCGCTGCACGGCTTCGCCCGCAGTCTGGCCTGGGACGTGGGCCGTGACGGTGTCCTGGTGAACGTCGTGTGCCCGGGGCTGACCACCACCGAGCGCGTGCTCACCGGGCTGCCCGACGAGATCCGCGAGCGTGAGCTCGGCTCGACCCCCACCGGTCGGCTCAGCAGCCCCGAGGACATCGCCGGCGCGGTGCTCTTCCTGGGCTCGGCGGCCAACGCCAACACGACGGGCCAGACCCTCACGGTCTCCGGCGGCCGCTGA	MDMGLTGRRVLVTGGSSGIGAAVARAYADEGARVALTYRGGDEAAERLARELGAGRHAAMAVRYSLGEPDTVESAVATVTERWGGVDVLVANAVRWAPRRAPGTRFEEVASGDWRGFLDDNLAPTLRTVQLVVAGMRARSWGRIVLISSHVALDGHRGQEFYGAAKSALHGFARSLAWDVGRDGVLVNVVCPGLTTTERVLTGLPDEIRERELGSTPTGRLSSPEDIAGAVLFLGSAANANTTGQTLTVSGGR	MTGLLDGKRILVSGIITDSSIAFHIARVAQEQGAQLVLTGFDRLRLIQRITDRLPAKAPLLELDVQNEEHLASLAGRVTEAIGAGNKLDGVVHSIGFMPQTGMGINPFFDAPYADVSKGIHISAYSYASMAKALLPIMNPGGSIVGMDFDPSRAMPAYNWMTVAKSALESVNRFVAREAGKYGVRSNLVAAGPIRTLAMSAIVGGALGEEAGAQIQLLEEGWDQRAPIGWNMKDATPVAKTVCALLSDWLPATTGDIIYADGGAHTQLL	94.05	gnl|BL_ORD_ID|1964|hsp_num:0	1574			12	576	isoniazid
BGC0000246.1|Mithramycin_5 # 3382 # 4977 # -1 # ID=1_5;partial=00;start_type=GTG;rbs_motif=AGGA/GGAG/GAGG;rbs_spacer=11-12bp;gc_cont=0.734	BGC0000246.1|Mithramycin_5 	3382	4977	-	Loose	550	180.644	Nocardia farcinica rox	34.11	3007210	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	GTGGCTGACCCGACCCGGGTGCTCGTGGCGGGGGCCGGCCCGGTCGGTCTCACCGCCGCCCATGAACTCGCCCGGCGGGGGCTGCGGGTGCGGCTGATCGACGCCGCGCCCCGCCCCGCGGCCACCAGCCGCGCCGTGGCCACCCACCCGCGGACCCTGGAGACGTACGACCAGATGGGCGTCATCGAGGAGATCCTCGAGAACGCCCAGCAGATCCGCGCGTTCACCATGTTCAGCCGGGGTCGCCGGCTGGTGCGGCTGGACGCCGACTACACGACCATGCCGACGCGCTTCCCGTTCACGGCGATCGTCGAGCAGGTGGACACCGAGGCCGTGCTGCGCTCCGCGGTGGCCCGGCTCGGCGTGGACGTCGAGTGGGAGACGCGGCTAACCGGGTTCTCCCAGGACGCGGAGGGTGTGGACGTCACACTCGAACACGCCGACGGGACCACGGAGTCCACTCGGGTGCCCTGGCTGGTCGGCTGCGACGGCGGCCACAGCACCGTGCGCAAACTGCTCGGACTGCCCCTGCTCGGTGAGTCCAGCGAGACCTGGATGTTGGCCGACGCCCCCGTCGACGTGGACCTGCCGCGCGACAGCATCTACTGGGTCCACACCGGCTCCCAGGCCCTGATGATGGTGCCCTTCCGACGCGGCGGCCGGTGGCGTCTGCTGGACACGACCACCGCCGAGCCCGGCACCGACGCCGCCGTGATCGCCGACCGCTTCACGCGCAACTCGGCCCCGGCCTCGGCCGTCCGCCAGGTGCGCACCCCCACTTGGACGTCGGTCTTCACCTTCCAGCAGCGGATGGTGCCGCGCATGGGCGAAGGCCGGGTCTTTGTCGCGGGTGACGCCGCCCATGTGCACAGCCCGGCCTCCGGGAGGGGCATGAACACGGGCGTCCAGGAGGCGTACAACCTGGCCTGGAAGCTGGCGCTGGTCGCCGAGGGACACGCGGAACGGGAACTGCTCGACAGTTACAGCCTGGAGCGGGTACCGATCGGCGAGCGGTTGCTCGGCTCGACCAAGAAGGCGACCTTCCTGGTGCAACTGAAGAACGCCTTCGCGCCGATCGCCCTCCCCGTCGTCTTCGGCCTCATCCGCAACGTCCCGCCGCTGCGGAGGAAGGTGCAGCGCCAGGTCCTGGGCGGCATCTCCGGACTTCAGCTCGACTACCCCGACTCACCGCTGACGCGGCCCGCCGCCACCGGTGCCGGGCCGCGTCCGGGCACCCGCGCCTCGGTGGGATCGGGCGCCGACCCGGCCGACCCCGGCTGCCGGGCCTGGGCGGAGGAACTGCGCGACACGCGCTGGACGCTGGCGGTGACGCCGGATGCGGTGGCCGGGGCACCGGCGGCGAACAGCTGGTTGTCCGTGCGCACGCTCGGCGACGGCAGCCAGGGGCCCGGCCCGCTTGCCGACCCGAACGGCCGGCTGCGCGCCGCGTTGGGACTCGCGTCCGGCGGCTGGCTCTTGGTCCGCCCGGACGGTTACGTCGCCGCGCGCGGCCGGGCACTCGGCGGCGCGGACCTGCGGCAGGCCCTGGCCGCCGCGGGTCTGCGCGACGAACAGCACGTCCTCCCCCACTCGTGA	MADPTRVLVAGAGPVGLTAAHELARRGLRVRLIDAAPRPAATSRAVATHPRTLETYDQMGVIEEILENAQQIRAFTMFSRGRRLVRLDADYTTMPTRFPFTAIVEQVDTEAVLRSAVARLGVDVEWETRLTGFSQDAEGVDVTLEHADGTTESTRVPWLVGCDGGHSTVRKLLGLPLLGESSETWMLADAPVDVDLPRDSIYWVHTGSQALMMVPFRRGGRWRLLDTTTAEPGTDAAVIADRFTRNSAPASAVRQVRTPTWTSVFTFQQRMVPRMGEGRVFVAGDAAHVHSPASGRGMNTGVQEAYNLAWKLALVAEGHAERELLDSYSLERVPIGERLLGSTKKATFLVQLKNAFAPIALPVVFGLIRNVPPLRRKVQRQVLGGISGLQLDYPDSPLTRPAATGAGPRPGTRASVGSGADPADPGCRAWAEELRDTRWTLAVTPDAVAGAPAANSWLSVRTLGDGSQGPGPLADPNGRLRAALGLASGGWLLVRPDGYVAARGRALGGADLRQALAAAGLRDEQHVLPHS	MIDVIIAGGGPTGLMLAGELRLHGVRTVVLEKEPTPNQHSRSRGLHARSIEVMDQRGLLERFLAHGEQFRVGGFFAGLAAEWPADLDTAHSYVLAIPQVVTERLLTEHATELGAEIRRGCEVAGLDQDADGVTAELADGTRLRARYLVGCDGGRSTVRRLLGVDFPGEPTRVETLLADVRIDVPVETLTAVVAEVRKTQLRFGAVPAGDGFFRLIVPAQGLSADRAAPTLDELKRCLHATAGTDFGVHSPRWLSRFGDATRLAERYRTGRVLLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAAIGGWAPPDLLDSYHDERHPVAAEVLDNTRAQMTLLSLDPGPRAVRRLMAELVEFPDVNRHLIEKITAIAVRYDLGDGHDLVGRRLRDIPLTEGRLYERMRGGRGLLLDRTGRLSVSGWSDRVDHLADPGAALDVPAALLRPDGHVAWVGEDQDDLLAHLPRWFGAAT	112.26	gnl|BL_ORD_ID|4834|hsp_num:0	5821			9	1113	rifampin
BGC0000246.1|Mithramycin_6 # 4970 # 5269 # -1 # ID=1_6;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.690	BGC0000246.1|Mithramycin_6 	4970	5269	-	Loose	250	26.5646	AAC(6')-29b	30.77	3002584	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	GTGGTGACCTTCGTCAACAAGCTGACCGTCAACGGCGACATCGAGGAATTCCTCACGATCAAGCGGTCGCTGACCGAGTTCATGTCCGCCCAGCCCGGATACCGCAGCTCCACCACGCTGCGCCAGGTCGGCCGGCCCGACGTGTTCATCGAGCTGGCCGAGTGGGACGACGCCGCCTCCCACCAGGCAGCGGTGCGCAGCGAGGAGTTCCAGGCGCGGGTCAAGGGCCTCGGTGCGCTGGCGAGCGTGGACCCGGGGCTCTACGAGGAGGCCTCCGAGGACGGGGCCGGCCGTGGCTGA	MVTFVNKLTVNGDIEEFLTIKRSLTEFMSAQPGYRSSTTLRQVGRPDVFIELAEWDDAASHQAAVRSEEFQARVKGLGALASVDPGLYEEASEDGAGRG	MSVSILPVKEQDAADWLALRNLLWLADDHASEIEQYFSGGFEEPAEVLIARDATGAAVGHVELSIRHDLEELQGIKTGYIEGLYVAPSHRSTDLVRRFLRESEKWALEQGCSAFASDRSDRVITHRKFAGSAV	74.44	gnl|BL_ORD_ID|607|hsp_num:0	659			183	300	dibekacin; amikacin; kanamycin A; tobramycin; isepamicin
BGC0000246.1|Mithramycin_7 # 5313 # 6857 # -1 # ID=1_7;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.748	BGC0000246.1|Mithramycin_7 	5313	6857	-	Loose	1000	51.2174	almE	23.86	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	GTGTCTGAGCTCCCGCCCGGGCCGGCGGTACCGCTGGACGGGTTGCTGCGCCTGGCCGCCGAGCGGCACCCGGAGCAGGTCGCCGTGCGCGACGAGCGCGGAGCCGTCGACTACGCCGGACTCGACGCCCGCGCCGACCGGTTCGCCCGCGCCCTGCTGCGGCTGACCGGCGGCCGGCCGACGGCCGTCGGCGTGGCGAGCGTGCTGGACCCGGTGTTCGCGGCGGCCTTCTACGGCACCAGCCGCAGCGGCAACCGCGTCGTGCTGGTCAACCCGCTGGTGCGCGAACCCGTCCTGGAGCACGTCTTCCGCACGGCCGGCATCGAGATCGCGCTGGTCTCCGCCGAGACCCGGTCCCCTGGCGGCCGTCGCGCCGCTCTCCCCGACCTGCGGGAGGTCTACGTGGTCGACGCGGACCGGACCGGGCCGCCGCCCCCGGGAACCCGCCCCCTGGACGACCTCCTCACCGAGGACGGCACGGCCGCGCTGCCCGACCCGGCCGGTGTCGACCTGGACTCCGTCGTCTGCGTGCAGTTCACCAGTGGCACCACCGGTCCCCCGAAGGGCGTCCGGCTCACCCACCGCAACCTGGTGGCCAACGCCGCCCAGGCGGCACACGCACTCGGCCTCGACGCCGGCAGCGTCTGCCTCAACCACCTGCCGCTCTACCACGTCATGCACCTCGACTCGGCCGTGTACGCGGGCGCCACCCAGGTGCTGTGCCACGACCCCGACCCGGTCGCCTCGGTCGCCGCGGCGGCCGAGGCCGGAGCCACCCACTACTTCGGGTTGCCGGTACGGCTGGCCAGACTGGCGGCGGACCCGCGGCTGGCCTCGGTCGTCCCCGGGCCCGAACTGGGGCTGGTGCGCTCCGGCGGCTCCCGGCTCGCCCCCGCCGTCGCGGCCCGCCTGCGCGAGCGGCTCGGCGTGCCGGTCATCCAGGGATACGGGCTCGCCGAACTCTCGCCGCTCAGCCACAACGACCGTCCGGAGCGGAGCAAGCCCGGCTCGGTCGGTCCGGCCGTCCCCGGCACCGAGTGCCGCATCGTGGACCTGGAGACCGGAGCCGCCCTTGACCCCGGCCGGCCGGGCGAGGTCCTGCTGCGCGGACCGCAGCTGATGGCCGGGTACCTCGGCCTGCCGGACGCCCCGGACATCGACGCCGCAGGCTGGTTCCATACCGGCGACGTCGGCTACCAGGACGAGGACGGCTGGCTGTTCCTGGTCGACCGCATCAAGGACGTCTTCAAGGTCGACAACGAACTCGTGTCGCCGAGCGAGATCGAACAGGTCCTGCTGCAGGACCCGGACGTCGCCGACTGTGTGGTGGCCGACCTGCCCGACGAGTTCAGCGGCGCCGTCGTCTGGGCCGGCGTCGTACCCGCCGGTGACGGGCCGGTGGACCTGAACCCGATCGTGGCCCGGGCCAACGCCCTGCTCTCCGACCACCAGCGCATCCGCCGCGCCGAACGGCTCACGGCCGTGCCCCGCTCCCCGAACGGCAAGACCGAACGAACGCGGCTGCGCGAGCGGCTGCGCGCCTAG	MSELPPGPAVPLDGLLRLAAERHPEQVAVRDERGAVDYAGLDARADRFARALLRLTGGRPTAVGVASVLDPVFAAAFYGTSRSGNRVVLVNPLVREPVLEHVFRTAGIEIALVSAETRSPGGRRAALPDLREVYVVDADRTGPPPPGTRPLDDLLTEDGTAALPDPAGVDLDSVVCVQFTSGTTGPPKGVRLTHRNLVANAAQAAHALGLDAGSVCLNHLPLYHVMHLDSAVYAGATQVLCHDPDPVASVAAAAEAGATHYFGLPVRLARLAADPRLASVVPGPELGLVRSGGSRLAPAVAARLRERLGVPVIQGYGLAELSPLSHNDRPERSKPGSVGPAVPGTECRIVDLETGAALDPGRPGEVLLRGPQLMAGYLGLPDAPDIDAAGWFHTGDVGYQDEDGWLFLVDRIKDVFKVDNELVSPSEIEQVLLQDPDVADCVVADLPDEFSGAVVWAGVVPAGDGPVDLNPIVARANALLSDHQRIRRAERLTAVPRSPNGKTERTRLRERLRA	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	92.45	gnl|BL_ORD_ID|4935|hsp_num:0	5928			603	1641	colistin A; colistin B
BGC0000246.1|Mithramycin_9 # 8009 # 8461 # 1 # ID=1_9;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.733	BGC0000246.1|Mithramycin_9 	8009	8461	+	Loose	200	25.7942	vanX gene in vanO cluster	33.33	3002954	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanX; glycopeptide resistance gene cluster	GTGACCGCGCCGACCGAGACACAGCCGCACTCCTCCGCCGGGTTCGGCTCCCTGTACGCGGAGATCCAGCAGTTCTACGCCCGCCACATGCAGCTCCTCGACGGGGGAGCCGCCGACGAGTGGGCGGCCGACTTCACCGAGGACGCGTCGTTCTCGGTGCCGACCGTGCCGGCACCGGTGGTGGGCCGGGACGCCCTGGCAGCCGCGGTGCGGCGCACCGCCGAGTCCCTGGCCTCCACTGGTGAGCAGCACCGCCACTGGCCCGGCGTCTTCGACGTCCGGCCGCGGCGGGACGGCTCCGTGGTGGTCCACTCGTACACCACCGTGTACGCCTCACCGCGTGGCGGGGAGTCCCGCGTGCACCGCGTCTGCACCTGCACGGACGTCCTGGTCCGCGAGGATGGCCGGCTGCTCGTGCGGTCCCGCGAGGTCATCCGTGACGACCTGCGCTGA	MTAPTETQPHSSAGFGSLYAEIQQFYARHMQLLDGGAADEWAADFTEDASFSVPTVPAPVVGRDALAAAVRRTAESLASTGEQHRHWPGVFDVRPRRDGSVVVHSYTTVYASPRGGESRVHRVCTCTDVLVREDGRLLVRSREVIRDDLR	MNDDFVYVDDWVPGVRWDAKYATWDNFTGKPVDGYLANRIVGTRALCAALEQAREKAASLGFGLLLWDGYRPRRAVDSFLRWSEQPEDGQTKQRHYPNIDRPEMLEKGYVATQSGHSRGGAVDLTLYHLATGELAPMGGDHDLMDPISHHRARGIKPIESKNRELLRSIMEDCGFDRYDCEWWHYTLKREPYPDVYFDFPIT	74.26	gnl|BL_ORD_ID|1672|hsp_num:0	1699			117	276	vancomycin
BGC0000246.1|Mithramycin_12 # 11193 # 11450 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=3Base/5BMM;rbs_spacer=13-15bp;gc_cont=0.717	BGC0000246.1|Mithramycin_12 	11193	11450	+	Loose	800	23.0978	OprN	33.33	3000805	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCACCTGGAAGACCTCACCGCCGTGCTGCGCGAGTGCGCGGGCGAGAGCGAGAGCGCCGGTCTGACCACGGCCGCCCTCGACGTCTCCTTCGCCGACCTCGGCTACGACTCGGTCGCCGTCCTGGAGACCACGGCGCGCATCGAGCGCGATCACGGCGTCGTCCTCGACGAGGAGGCCGTTTCCGAGGCGGAGACCCTGGGCCAGTACCTCGCCCTGGTCAACGAGGCGCTCGCCGACGGCACCCGTGCGGCCTGA	MHLEDLTAVLRECAGESESAGLTTAALDVSFADLGYDSVAVLETTARIERDHGVVLDEEAVSEAETLGQYLALVNEALADGTRAA	MIHAQSIRSGLASALGLFSLLALSACTVGPDYRTPDTAAAKIDATASKPYDRSRFESLWWKQFDDPTLNQLVEQSLSGNRDLRVAFARLRAARALRDDVANDRFPVVTSRASADIGKGQQPGVTEDRVNSERYDLGLDSAWELDLFGRIRRQLESSDALSEAAEADLQQLQVSLIAELVDAYGQLRGAQLREKIALSNLENQKESRQLTEQLRDAGVGAELDVLRADARLAATAASVPQLQAEAERARHRIATLLGQRPEELTVDLSPRDLPAITKALPIGDPGELLRRRPDIRAAERRLAASTADVGVATADLFPRVSLSGFLGFTAGRGSQIGSSAARAWSVGPSISWAAFDLGSVRARLRGAKADADAALASYEQQVLLALEESANAFSDYGKRQERLVSLVRQSEASRAAAQQAAIRYREGTTDFLVLLDAEREQLSAEDAQAQAEVELYRGIVAIYRSLGGGWQPSA	18.01	gnl|BL_ORD_ID|293|hsp_num:0	172			345	453	ciprofloxacin; trimethoprim; chloramphenicol; norfloxacin
BGC0000246.1|Mithramycin_13 # 11481 # 12245 # 1 # ID=1_13;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.759	BGC0000246.1|Mithramycin_13 	11481	12245	+	Loose	450	84.3445	Escherichia coli fabI mutations conferring resistance to isoniazid and triclosan	28.4	3004045	protein variant model	G93S, F203V	I21V:1574	disinfecting agents and antiseptics; isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant fabI	GTGACCACGCACCACTCCACAGCCCCGGCCCTGACCGGCCGCACCGCGCTGGTGACCGGCGCCACCCGGGGCGTGGGCTTCGCCATCGCCCGCAAACTGTGCGCCCGCGGCGCCGACGTCCTGCTCGACTACGCCGAGGACGAGGCGAACGCCGCGCGGGCCGTCGGGGCGCTGGCCGGCCTGCCGGGCCGGGCCGCCGCCGTCCGGGCCGATGTCACCGTCGACTTCGACGCCCTGTGCGACGAGGTCGGGCAGCGCTTCGGCCACCTCGACATCTTCGTCCACAACACCTCCTACTTCCGGCCCGCGCCCACCCTCGCCACCACGCCGGAGCAGGTGGACCGCTCCCTGGCCGTGGCGCTGCGTCCCCTGCTCACCGGGGCCTCCCGGCTGGCCGGGCTAATGGCGGGACGCCCAGGCAGGATCGTCGCCGTCTCCAGCACCGGTGCCCACCGGGTGGTGCCCCGGTACGCCGGGGCGGGCATGGCCAAGGCCGCGCTGGAGTCCCTCGTGCGGTACCTCGCGGTGGAGCTGGCCGGACGCGGCATCGCCGTCAACGCGGTCGCCGCGGCCAAGGTCGACAAGGGGGACGGGACCGTTCCGGCCGAGGTCGCCGAGGCGATCACCGCACGTACGCCCGGGGGACGGCTCACCCGCCCCGAGGACGTCGCCGACGCCGTCAGCCTGCTGTGCACGGACGAGGCGCGCTGGCTGCAGGGCCAGGTCGTGACGGTCGACGGCGGCCTGGGTCTGGTGGCGGGCTGA	MTTHHSTAPALTGRTALVTGATRGVGFAIARKLCARGADVLLDYAEDEANAARAVGALAGLPGRAAAVRADVTVDFDALCDEVGQRFGHLDIFVHNTSYFRPAPTLATTPEQVDRSLAVALRPLLTGASRLAGLMAGRPGRIVAVSSTGAHRVVPRYAGAGMAKAALESLVRYLAVELAGRGIAVNAVAAAKVDKGDGTVPAEVAEAITARTPGGRLTRPEDVADAVSLLCTDEARWLQGQVVTVDGGLGLVAG	MGFLSGKRILVTGVASKLSIAYGIAQAMHREGAELAFTYQNDKLKGRVEEFAAQLGSDIVLQCDVAEDASIDTMFAELGKVWPKFDGFVHSIGFAPGDQLDGDYVNAVTREGFKIAHDISSYSFVAMAKACRSMLNPGSALLTLSYLGAERAIPNYNVMGLAKASLEANVRYMANAMGPEGVRVNAISAGPIRTLAASGIKDFRKMLAHCEAVTPIRRTVTIEDVGNSAAFLCSDLSAGISGEVVHVDGGFSIAAMNELELK	96.95	gnl|BL_ORD_ID|4712|hsp_num:0	2666			9	765	triclosan
BGC0000246.1|Mithramycin_14 # 12249 # 13559 # 1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=GGxGG;rbs_spacer=5-10bp;gc_cont=0.734	BGC0000246.1|Mithramycin_14 	12249	13559	+	Loose	550	62.3882	Nocardia farcinica rox	27.59	3007210	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGGACAAGACCACCGGCACCACGTCCTCCGGCACGCCCGCTCCCGACGAGGGGCTGCACACCGACGTCTGCGTCGTCGGCGGAGGGCCCGCGGGGCTCGCCCTCGCCCTGATGCTGCTGCGCTCGGGGGTGCGGGTCACCCTCCTGGAGAAGTCGGCACGGTTCGACCGTGCCTTCCGCGGCGAGATTCTCCAGCCTGGAGGCCAGCGCATCCTCGGCGACCTGGGCGTCCTCGCCGCGGCGCGCGCCGCCGGGGCGTGCGAACTCAACGGCTTCCAGCTCGTCGACCGTGACCGCGTCCTGCTCGACATCGACTACCGGCGGCTGCCCGCCCCGTACCGCCATCTGCTGGCGATGCCCCAGCGCCACCTGCTCGACGCGCTCCTGGAGCAGTGCCGGGCACTGCCCGGCTTCCGCTTCCTCGACGGACACCGGATCGGCGCCCTGGTGGAGGAGGACGGCCGGATCACCGGCGCCGTCGCCCGTGGCCCGGGCGGCCGGCGCACCGTGCGCGCCCGGGTCGTCGTGGGGGCCGACGGCGGGTTCTCCAAGACCCGTGCGCTGGCGGGGATCGGCGCGGGTCGGGTGGAGGCGTTCGGGCACGACGTGCTGTGGTTCACAGTGCGCGCGCCCGGCCGGCAGACCGGGTACGTCCGTATCCACCGCACCGCGGGAAACCCCGTCCTGGTGCACGACTCCCACCCCGACCGGTTGCAGATCGGCTGGACACTGCCGCACCGGAGCTGGCCGGAACTCGCCGCCCGGGGGGGCGACGAGGTCCGGGGCGAACTGACCACGGCGCTGCCGCAGTTCGCGGACCTCATCGAGGCCTCCGTGAGCGACCTGTCCGACCTCAGCCTGCTCGACGTCTACGCCGGGAAGGCCGACGCCTGGACGCGCGACGGCCTCGTGCTGATCGGCGACAGCGCCCACACGCACAGCCCGCTGGGCGCCCAGGGCATCAACCTCGCCCTTCAGGACGCGGCCGTGCTCCATCCGGTGCTGGTGGCGGCGCTGCGGGACGGGTGTGTGGACCAAGCGCGTTTCGCCCCGTACCTCGAGACCCGGATGCCCGCCGTGGACGTTGTCATGCGGATGCAGCAGATGCAGGCCAAAGGCATGTTCGGGACCGGCGGGCCGGTGGCCGACCGGCTGCGCTCGGGTGTCGCCCGGCTGATCCGGCACAGCCCGCTCGGCAGGAAGATCACCCACCGGGTGGCCTACGGGCATCCGGTGGTGGAGGTCCGTACCGATCTGTTCACCACCGGCCCGACCGCCCGTGCCGAGCGTACGGGCGGCCCGAAGGGATGA	MDKTTGTTSSGTPAPDEGLHTDVCVVGGGPAGLALALMLLRSGVRVTLLEKSARFDRAFRGEILQPGGQRILGDLGVLAAARAAGACELNGFQLVDRDRVLLDIDYRRLPAPYRHLLAMPQRHLLDALLEQCRALPGFRFLDGHRIGALVEEDGRITGAVARGPGGRRTVRARVVVGADGGFSKTRALAGIGAGRVEAFGHDVLWFTVRAPGRQTGYVRIHRTAGNPVLVHDSHPDRLQIGWTLPHRSWPELAARGGDEVRGELTTALPQFADLIEASVSDLSDLSLLDVYAGKADAWTRDGLVLIGDSAHTHSPLGAQGINLALQDAAVLHPVLVAALRDGCVDQARFAPYLETRMPAVDVVMRMQQMQAKGMFGTGGPVADRLRSGVARLIRHSPLGRKITHRVAYGHPVVEVRTDLFTTGPTARAERTGGPKG	MIDVIIAGGGPTGLMLAGELRLHGVRTVVLEKEPTPNQHSRSRGLHARSIEVMDQRGLLERFLAHGEQFRVGGFFAGLAAEWPADLDTAHSYVLAIPQVVTERLLTEHATELGAEIRRGCEVAGLDQDADGVTAELADGTRLRARYLVGCDGGRSTVRRLLGVDFPGEPTRVETLLADVRIDVPVETLTAVVAEVRKTQLRFGAVPAGDGFFRLIVPAQGLSADRAAPTLDELKRCLHATAGTDFGVHSPRWLSRFGDATRLAERYRTGRVLLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAAIGGWAPPDLLDSYHDERHPVAAEVLDNTRAQMTLLSLDPGPRAVRRLMAELVEFPDVNRHLIEKITAIAVRYDLGDGHDLVGRRLRDIPLTEGRLYERMRGGRGLLLDRTGRLSVSGWSDRVDHLADPGAALDVPAALLRPDGHVAWVGEDQDDLLAHLPRWFGAAT	92.18	gnl|BL_ORD_ID|4834|hsp_num:0	5821			6	1140	rifampin
BGC0000246.1|Mithramycin_15 # 13563 # 14336 # 1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.703	BGC0000246.1|Mithramycin_15 	13563	14336	+	Loose	400	26.9498	IND-9	39.29	3002265	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	IND beta-lactamase	ATGCGTATCGTCGACCTCTCCTCGCCCGTGGACGCCACGGCCTGGGAGCCCGACCCCGTCGTCCACGAGATCCTCACGCCGGCCGAGGGGGCCCGGCACATGAGCGAGGAGATGAAGGCCCACTTCGGCATCGACTTCGATCCGTCGGTGCTGCCGGAGGGCGAACTGCTGTCGCTGGACACGTTCACGCTCACCAGCCACACCGGGACCCATGTGGACGCGCCGTCCCACTACGGTTCGACGGGCGCGTACGGCACGGCGCGGCACATCCACGAGATGCCGCTGGACTGGTTCCACCGCCCGGCGATCCGGCTCGACCTGCGCGACCAGCCGGTGGGCGCCGTGGGAGTCGGGGTCCTGGAGCGGGAGATCGCCCGGATCGGCCGCGCCCCCCGGCCTTACGACATCGTCCTGCTGAACACCGGAGCCTCCGTGCACCTGGGCACCGAGAAGTACTTCACCGACTTCACCGGACTCGACGGCGAGGCCACCGACTTCCTGCTCGACCTGGGGGTCAGGGTCATCGGCACCGATGCCTTCAGCCTCGACGCGCCCTTCGGCGACATGATCCGCCGGTACCGGAAGACCGGTGACCGCTCCGTCCTGTGGCCCGCGCATTTCGCCGGCCGCCGGCGCGAGTACTGCCAGATCGAGCGCCTGAACAACCTTGAGGCCCTGCCCGGCGACTTCGGCTACACCGTCTCCTGCCTGCCGGTGAAGCTGGTCGGCTCCGGGGCGGGCTGGGCCCGCGCGGTGGCCCTGGTGGACGACTGA	MRIVDLSSPVDATAWEPDPVVHEILTPAEGARHMSEEMKAHFGIDFDPSVLPEGELLSLDTFTLTSHTGTHVDAPSHYGSTGAYGTARHIHEMPLDWFHRPAIRLDLRDQPVGAVGVGVLEREIARIGRAPRPYDIVLLNTGASVHLGTEKYFTDFTGLDGEATDFLLDLGVRVIGTDAFSLDAPFGDMIRRYRKTGDRSVLWPAHFAGRRREYCQIERLNNLEALPGDFGYTVSCLPVKLVGSGAGWARAVALVDD	MKKSIQFFIVSLLLSPFANAQVKDFVIEPPISKNLYIYKTFGVFGGKEYSANAVYLVTKKGVVLFDVPWEKVQYQSLMDTIKKRHNLPVVAVFATHSHDDRAGDLSFFNKKGIKTYATAKTNELLKKEGKAVSSNIINTGKAYHIGGEEFVVDFIGEGHTVDNVVVWFPKYKVLDGGCLVKSTSATDLGYIKEANVEQWPQTMNTLKSKYSQATLIIPGHDEWKGGGHVEHTLELLNKK	107.53	gnl|BL_ORD_ID|1331|hsp_num:0	1455			405	486	
BGC0000246.1|Mithramycin_17 # 15155 # 16420 # -1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.686	BGC0000246.1|Mithramycin_17 	15155	16420	-	Loose	450	27.335	ermZ	30.86	3004605	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGGACATCTATGGGACCGCGCGGGCAGTGACCACCTGCCCGATGTGCGGAGCGCAGGACTGGCAGGAGGTCGTGGACTTCGGCCCCGTCCCCCTGGCGGACAGCTTCCTCGAACCCGCCGCGTCCTACGACGACGAACCGCGCTACCCGCTGGCCGTCGTCTCCTGCGCATCCTGCCGCCTGATGAGCCTGACACACGTCGTGGACCCCGAAGTCCTGTACCGCACGTACCCCTACACCACCTCCGACTCGGAGACCATCAAGAAGCACATGGGGCATGTCGTCGCCGGTGTGCGTCCGAGCGCTTCGGCATCCCCCGAGGGCAGCTTCGTCCTGGAGATCGGCAGCAACACCGGCTCCCAGCTGAAGGCGTTCCAGAACGCCGGGATGCGCACCCTCGGCATCGACCCGGCCCGCAACATCGCCGCGGTGGCCAACGAGCGGGGCATCGAGACGCTGCCGGAGTTCTTCTCGGTCGACACCGCCGCCCTGGTGAAGAAGACCCACGGCACGCCCCAGCTGGTCCTCGGCCGGCATGTCTTCGCGCACATCGACGACGTGTCCGCGGTCGCCGAGGGCGTCCGCGATCTGCTGGGCCCGGACAGCCTGTTCGCCATCGAGGTGCCGTACCTGGTGGACATGCTGGAGCGCAACGAGTTCGACACCATCTACCACGAGCACCTGTCCTACATCGGCGTCGGCTCCCTGGTCGCCCTCTTCCGACGGCACGGGCTGCGTGTGGTGGACGTCGAACGCCTCGCGGTGCACGGCGGATCCATCCTGGTCTTCGTCGGGCTGGACGAGGGCACCCGGGCGACGGCGCCCGTCGTGGAGGAGCTGATCGCGCTGGAGAAGGAGCGCGGTCTGTACGAGGACGCCACCTACGAGCGGTTCGCCAGGCACGTCGCGGAGATCACCGCCGAACTGACCTCGATGGTCCGCTCGCTGCGGGCCGAGGGCAAACGGATCGCCGGGTACGGGGCGCCCGCGAAGGGCAACACCCTGCTGAACGTCTGCGGGCTCACCGCGGACGACCTGGAATTCTGCTGCGACACCACCGAGTTCAAGCAGGGCCTGGTGCTGCCCGGCACGCACATCCCGGTCCGCAGCCCCGAGTACGCCAAGACCCAGGCCATCGACTACTACCTGCTGCTGGCCTGGAACTACGGCGAGGAGATCCTCGCCAAGGAGGGGCCGTTCCTGGCGGACGGCGGACGGTTCATCCTGCCCAACCCGCGGCCGTCGATCGTCCCGCCCGGGGAGTGA	MDIYGTARAVTTCPMCGAQDWQEVVDFGPVPLADSFLEPAASYDDEPRYPLAVVSCASCRLMSLTHVVDPEVLYRTYPYTTSDSETIKKHMGHVVAGVRPSASASPEGSFVLEIGSNTGSQLKAFQNAGMRTLGIDPARNIAAVANERGIETLPEFFSVDTAALVKKTHGTPQLVLGRHVFAHIDDVSAVAEGVRDLLGPDSLFAIEVPYLVDMLERNEFDTIYHEHLSYIGVGSLVALFRRHGLRVVDVERLAVHGGSILVFVGLDEGTRATAPVVEELIALEKERGLYEDATYERFARHVAEITAELTSMVRSLRAEGKRIAGYGAPAKGNTLLNVCGLTADDLEFCCDTTEFKQGLVLPGTHIPVRSPEYAKTQAIDYYLLLAWNYGEEILAKEGPFLADGGRFILPNPRPSIVPPGE	MTLKSPLPPQSVSAPADSRSTARREWGQNFFRTAAAACRFSAQLDGSDTIPPDSPNDLMTVEIGAGSGRVTKVLASPGTPLLAVEIDPRWARRLAAESLPDVTVVNEDFLTLQLPGQPVRLIGNLPFVTGTRMLRRCLDMGPARMRQGVFLLQREYVGKRTGAWGGNLFNAQWEPWYSFDRGLAFSRQDFTPVPRADTQTLMVAPHRRPSVPWREKAAYQRFVQRVFDTGQMTVGDAARKVLRRGHAQFVRGAGVRPADRVKDLTVPEWTALFRAYGRTADR	149.29	gnl|BL_ORD_ID|225|hsp_num:0	3303			159	381	spiramycin
BGC0000246.1|Mithramycin_18 # 16450 # 17445 # -1 # ID=1_18;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.746	BGC0000246.1|Mithramycin_18 	16450	17445	-	Loose	1300	26.9498	mdtO	35.0	3003549	protein homolog model	n/a	n/a	nucleoside antibiotic; disinfecting agents and antiseptics	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGAGCGCCGTGCCCGAGGACCGTGGCCCGCTCCGCCTGGGCCTGCTGGGCTGCGCCGGCTTCGCCCGGCGTCGCGCCCTGCCCTCGCTCGCCCGCCTCACGGAGATCACCCTCACCGCGGTCGCCAGCAGGGACGCCGGCAGAGCGAAGCTCTTCGCCGGTGAATTCGGCGGCGAACCGGTCGCCGGATACGAGGAACTGCTCGCCCGGGACGATCTCGACGCGGTGTACGTACCGCTGCCCGCCGCGCTGCACGCCCCCTGGACCGGCCGGGCGCTCGAAGCCGGACTGCACGTCCTGGTGGAGAAACCGGCGGCGGCCACGGCCGCGGAGGCCGACCGTCTGACCCGCGCGGCCCGCGAGCGCGGCCTGGTCGTGATGGAGAACTTCGGTTTCGTCCACCACGCCCAGCAGGAGGCGGCCCGTTCCCTGCTGGACGAGGGCGCCATCGGGGAACTGCGGTCGCTCACGGCCGAGTTCGCCTTCCCCCCGCTGCCGGACACCGACATCCGCTACCAACCGGGCCTCGGCGGCGGTGCGCTGCTGGACGCGGGCGTGTACCCGATCCGGACGGCCCGGCTGTTCCTGGGCGACGAGCTGGAGGTGACCGGTGCCTCGCTGCGCGAGGACCCCGGCCGCGGGGTGGACGTCGCCGGTGCGGCGCTGCTGACCGGGCCGACCGGGATCAGCGCCCATCTGGGCTTCGGCTTCGTCCACTCCTACCGCTGCGGCTACACCCTGTGGGGCTCGGCGGGACGGATCGGCCTGAACCGTGCCTACAGCGCCCGGGACGACTTCACGCCGACGCTCACGCTGGAGCGCGACGGACGGGTGGAGGAGCGCCGGCTGGTGCCCGACCAGCAGTTCACCACGCTCTTCCGGCGGTTCGCCGCCGCCGTCCGTGACCAGGACGTCGCCGGTCCGGCCCACGACCTCGCCCAGCAGGCGCGCCTGGTGGAGCGGATCGCCGCCACCGCGCGGCGCCTTCCCCTGTGA	MSAVPEDRGPLRLGLLGCAGFARRRALPSLARLTEITLTAVASRDAGRAKLFAGEFGGEPVAGYEELLARDDLDAVYVPLPAALHAPWTGRALEAGLHVLVEKPAAATAAEADRLTRAARERGLVVMENFGFVHHAQQEAARSLLDEGAIGELRSLTAEFAFPPLPDTDIRYQPGLGGGALLDAGVYPIRTARLFLGDELEVTGASLREDPGRGVDVAGAALLTGPTGISAHLGFGFVHSYRCGYTLWGSAGRIGLNRAYSARDDFTPTLTLERDGRVEERRLVPDQQFTTLFRRFAAAVRDQDVAGPAHDLAQQARLVERIAATARRLPL	MSALNSLPLPVVRLLAFFHEELSERRPGRVPQTVQLWVGCLLVILISMTFEIPFVALSLAVLFYGIQSNAFYTKFVAILFVVATVLEIGSLFLIYKWSYGEPLIRLIIAGPILMGCMFLMRTHRLGLVFFAVAIVAIYGQTFPAMLDYPEVVVRLTLWCIVVGLYPTLLMTLIGVLWFPSRAISQMHQALNDRLDDAISHLTDSLAPLPETRIEREALALQKLNVFCLADDANWRTQNAWWQSCVATVTYIYSTLNRYDPTSFADSQAIIEFRQKLASEINKLQHAVAEGQCWQSDWRISESEAMAARECNLENICQTLLQLGQMDPNTPPTPAAKPPSMAADAFTNPDYMRYAVKTLLACLICYTFYSGVDWEGIHTCMLTCVIVANPNVGSSYQKMVLRFGGAFCGAILALLFTLLVMPWLDNIVELLFVLAPIFLLGAWIATSSERSSYIGTQMVVTFALATLENVFGPVYDLVEIRDRALGIIIGTVVSAVIYTFVWPESEARTLPQKLAGTLGMLSKVMRIPRQQEVTALRTYLQIRIGLHAAFNACEEMCQRVALERQLDSEERALLIERSQTVIRQGRDLLHAWDATWNSAQALDNALQPDRAGQFADALEKYAAGLATALSRSPQITLEETPASQAILPTLLKQEQHVCQLFARLPDWTAPALTPATEQAQGATQ	48.46	gnl|BL_ORD_ID|1893|hsp_num:0	2056			1623	1743	acriflavine; puromycin
BGC0000246.1|Mithramycin_19 # 17442 # 18977 # -1 # ID=1_19;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.702	BGC0000246.1|Mithramycin_19 	17442	18977	-	Loose	500	29.261	STA-1	21.43	3007000	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	STA beta-lactamase	CTCGAGCGCGACTCCAGCCTGGGTGCCGACGGTGGCCCGAGCGCGCTGCCGATGCCTGCGATGGGAGAGACATCCATGACTCAAGCGATCATGAGCAGAAAGCATCCAGCGGTCCCCCCGGACGGCCTCGACGCGCCGGATCTGAGGCGCATCGCCGAATCGGCGGCGGCCGACAGCGGACTGCTGTCCCTGGGTGGTGTCCACGACTGGTTCGAGGAGCGCCGCAAGGCCATCCGGATGGACGTGAGGCGCATCCCCTTCGCCGAGCTCCAGCGCTGGGGCTTCCACCCGGTCACCGGGAATCTGGCGCACGACAGCGGCCGCTTCTTCACCGTCGAAGGGCTGCGGGCTCGCTCCGAGGGCCCGGACCCCGTCTCCTGGTCCCAGCCGATCATGCACCAGCCGGAAGTGGGTTTCCTCGGCATCCTGGTCAAGGAGTTCGACGGTGTCCTGCACTGCCTGATGCAGGCGAAGGCCGAGCCCGGCAACGCCGAGGGACTCCAGTTGTCGCCCACGGTGCAGGCCACCCGCAGCAACTACACGGGCGTGCACGAGGGCAGCGCCGTGCGGTACCTGGAGTACTTCACGGACCCCGGCAAGGGCCGGCCGCTGGTCGACGTGCTCCAGTCCGAGCACGGTTCCTGGTTCTTCCGCAAACGCAACCGCAATCTCGTCGTCGAGGCCGTCGGCGACGTGCCCGAGCACGAGGACTACCGCTGGCTGACCCTCGGTCAGGTCCGCCGGCTGCTCGGCGTCCCGGACCTGGTCAACATGGACACTCGGACGGTCCTGGCCTGCCTCCCCGTCGCCCCGCCGGACGGTTCCCTCGAGGGAGTCACGACCGACGGTTCCCGCGGGGCGGCCGTGGCCGCCCTGACCGCCTCCCTGTCCGCGCAGGCCCCCGCCGCGCACACCCTGCCCGAGCTGCTGCGCTGGTTCAACGGGCTCAGGGCGCGCAGCGAGGTCGCCGCGCAGCTCGTCCCGCTGACCTCCGTGGACGGCTGGGTCCGCGACACGGACGAGATACGCCACACCAGTGGACGGCACTTCGCGATCGTCGCCGTGTCTGTGGAGGCCGGCAACCGCGAAGTCAAGGGGTGGACCCAGCCGCTGCTCAGCCCGCGCGGCACCGGGGTGGTGGCGTTCCTGGCCAAGCGGATCGACGGCGTCCTCCACGTCCTGGCGCGCGCCCACCCGGAACCGGGCTACGTCGACCTCATCGAGCTGGCCCCGACCGTCCAGTGCGTCCCCGACGACCACGCTCATCTCCCCCCCGAACAGCGGCCCAGGTTCCTGGACCAGGTGCTCGCGGCCCGGCCGGAGCAGATCCTCTACGACGCCGTGCAGTCCGAGGAGGGCGGCCGTTTCTACCGGGCGCTGAGCCGCTACCTGGTGGTCGAGACGGACGAGGATCCCGTCGTGCCCGACGACTACCGCTGGATGACGGTGGCGCAGCTGGTCGCCCTGCTCCAGCACAGCAACTACTGCAACATCCAGGCCCGCAGCCTCATCGCCTGTCTGCAGTCCGTCTGGTGA	LERDSSLGADGGPSALPMPAMGETSMTQAIMSRKHPAVPPDGLDAPDLRRIAESAAADSGLLSLGGVHDWFEERRKAIRMDVRRIPFAELQRWGFHPVTGNLAHDSGRFFTVEGLRARSEGPDPVSWSQPIMHQPEVGFLGILVKEFDGVLHCLMQAKAEPGNAEGLQLSPTVQATRSNYTGVHEGSAVRYLEYFTDPGKGRPLVDVLQSEHGSWFFRKRNRNLVVEAVGDVPEHEDYRWLTLGQVRRLLGVPDLVNMDTRTVLACLPVAPPDGSLEGVTTDGSRGAAVAALTASLSAQAPAAHTLPELLRWFNGLRARSEVAAQLVPLTSVDGWVRDTDEIRHTSGRHFAIVAVSVEAGNREVKGWTQPLLSPRGTGVVAFLAKRIDGVLHVLARAHPEPGYVDLIELAPTVQCVPDDHAHLPPEQRPRFLDQVLAARPEQILYDAVQSEEGGRFYRALSRYLVVETDEDPVVPDDYRWMTVAQLVALLQHSNYCNIQARSLIACLQSVW	MHPPLRPHPLWCSLRPATLALLLGVFGCRTSVPAPRPAAEPFTSITEDLRIQPLAPGVWRLVALSGEEWGHIPANGLVIAEGGGVLLVDPGWTEAQGERLLQWVEDTLKVPVHAGVATHFHADRTGGLRALQARGIPTHALALTAALTSQQDRPAPTHLFPGPAQQLGPVELFFPGPGHAPDNITVWHAASGILFGGCMVKDLKASSLGNLSDADLASWPRSVESLQARYPAARTVIPGHGEPGDTSLLAHTLELLRAGSR	195.79	gnl|BL_ORD_ID|4596|hsp_num:0	5666			198	657	
BGC0000246.1|Mithramycin_10 # 8642 # 9910 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=5-10bp;gc_cont=0.710	BGC0000246.1|Mithramycin_10 	8642	9910	+	Loose	750	182.57	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	30.9	3003463	protein variant model	F413L	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	ATGAACCGTCGCGTCGTCATCACCGGCATCGGGGTCGTGGCCCCGGGGGCGGTGGGAGTCGAGGCGTTCTGGGAGCAGCTCACCGCGGGCCGTACGGCCACCCGGACGATCAGTCTCTTCGACGCCTCCGCGTTCCGCTCCCGGATCGCTGCCGAAGTGGACTTCGACGCGGCCCGGCACGGCTTCGGCCCCGCCGAGGCCGAACGCCTCGACCGGGCCACCCAGTTCGCCCTCGTCAGTGCCCGCGAGGCCGTCGCCGACGCCGGCCTCGACGGCAAGACCGACCCGTCGCGCACCGGCGTGGCGCTCGGCAGCGCGGTCGGCTGTACGACGGGTCTGGACACCCAGTACAACGTCGTGAGCGAGGGCGGCTCCGACTGGTACGTCGACCACACCCGCGCGGTCGACCATCTCTTCGACTACTTCGTGCCCAGCTCCATGGCCGCCGAGGTCGCCTGGAGCATCGGTGCGCAGGGCCCCGTGGCGCTGATCTCCACGGGCTGCACCTCCGGTCTCGACTCCCTCGGTCACGCCGTCGCGCTGATCCGGGAGGGCAGTGCGGACGTGATGGTCGCAGGCGCGACCGAGGCACCGATCTCACCGATCACCGTCGCCTGCTTCGACGCCATCAAGGCCACCTCGCCGCGCAACGACGACCCGGCCACCGCGTCCCGGCCGTTCGACCGCAGCCGCAACGGCTTCGTGCTCGGGGAGGGCAGCGCCGTGCTCATCCTGGAGAGCCTCGAAAACGCCCGCCGCCGCGACGCCCACGTCTACGCCGAGATCTCGGGGTTCGCCAGTCGCTGCAACGCGTACCACATGACGGGGCTGCGGCCCGACGGCATCGAGATGGCGGAGGCGATCCGCACCGCTCTCGACGAGGCACGCCTGGACCCCACGGCCGTCGACTACGTCAACGCGCACGGCTCCGGCACCAAGCAGAACGACCGGCACGAGACCGCCGCCTTCAAGCGCAGTCTCAAGGACCACGCCTACCGGGTCCCGGTGAGTTCCATCAAGTCGATGATCGGGCACTCGCTCGGTGCCATCGGCTCCCTGGAGGTGGCCGCCAGCGCGCTGGCCATCGAGCACGACACGGTACCTCCGACGGCCAACCTGCACGACCGGGACCCGGCCTGCGACCTCGACTACACCCCGATCACCGCCCGTGAACAGCGCACCGACACCGTCCTGAGCGTGGGCAGCGGATTCGGCGGCTTCCAGAGCGCCATGGTGCTGACGGCGCCCGGACTCCGGGAGGCGGCATGA	MNRRVVITGIGVVAPGAVGVEAFWEQLTAGRTATRTISLFDASAFRSRIAAEVDFDAARHGFGPAEAERLDRATQFALVSAREAVADAGLDGKTDPSRTGVALGSAVGCTTGLDTQYNVVSEGGSDWYVDHTRAVDHLFDYFVPSSMAAEVAWSIGAQGPVALISTGCTSGLDSLGHAVALIREGSADVMVAGATEAPISPITVACFDAIKATSPRNDDPATASRPFDRSRNGFVLGEGSAVLILESLENARRRDAHVYAEISGFASRCNAYHMTGLRPDGIEMAEAIRTALDEARLDPTAVDYVNAHGSGTKQNDRHETAAFKRSLKDHAYRVPVSSIKSMIGHSLGAIGSLEVAASALAIEHDTVPPTANLHDRDPACDLDYTPITAREQRTDTVLSVGSGFGGFQSAMVLTAPGLREAA	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	101.44	gnl|BL_ORD_ID|1968|hsp_num:0	1943			84	1239	isoniazid
BGC0000246.1|Mithramycin_16 # 14409 # 15152 # -1 # ID=1_16;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.749	BGC0000246.1|Mithramycin_16 	14409	15152	-	Loose	500	25.409	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid	26.39	3003393	protein variant model	I194T	n/a	isoniazid-like antibiotic	antibiotic target alteration	isoniazid resistant inhA	GTGGCACGGACGACGGAACGCGCCCTGAGCGTCGTCGTCACCGGCGGTGGTTCCGGCATCGGCCGGGCCACCGCCCGTGCGTACGCCGCCCAAGGCGCACACGTGCTGGTCGTGGGGCGGACCGCCGGGCATCTGGAGGAGACCGCCGAGGGGCAGCCGCGCATTCGGGCGTTCGTCGCCGACCTCGCCGACCGCGACGCTCCCGAGCGGATCGTGGCGGCGGCGCTGGACGCCACCGGCGGGATCGACGTCCTGGTCAACAACGCCGCCGTCCCGTGGCGCGCCCGGCTCGGGGAGATCGACCGGGAGCGCGCCGAGCGGCAGGTCGCCACCAACCTGCTGGGCCCGCTGTTCCTGACCCAGAGCGCGGTGCCGCACATGCCGGCCGGCGCGACGGTGGTCAACATCAGCTCCAACCCGCCGACGCGCGGCTGGCCGGCCAACTCGGTCTACGGCAGCACCAAGGTCGGCCTGGACTTCCTCACCCTCACCTGGGCCGTGGAGCTGGCGCCGCGCGGGATCAGAGTCGTCTCGGTGGCTCCGGGGCCAACGCTGACCCCGGGCCTCACCCGGGCCAGGTCCGGCCAGCCGCCTCGGCAGCGCGACGACTTCTCCCGCGTCCCGCTGGGCCGCCCCGCCCGGCCGGAGGAGATCGCCTGGTGGATCACCCAGGTGACCCGTCAGGAGGCCGGCTATCTGACCGGTGCGGTGCTGCGCGTCGATGGCGGCCTGAGCGTGGGCTGA	MARTTERALSVVVTGGGSGIGRATARAYAAQGAHVLVVGRTAGHLEETAEGQPRIRAFVADLADRDAPERIVAAALDATGGIDVLVNNAAVPWRARLGEIDRERAERQVATNLLGPLFLTQSAVPHMPAGATVVNISSNPPTRGWPANSVYGSTKVGLDFLTLTWAVELAPRGIRVVSVAPGPTLTPGLTRARSGQPPRQRDDFSRVPLGRPARPEEIAWWITQVTRQEAGYLTGAVLRVDGGLSVG	MTGLLDGKRILVSGIITDSSIAFHIARVAQEQGAQLVLTGFDRLRLIQRITDRLPAKAPLLELDVQNEEHLASLAGRVTEAIGAGNKLDGVVHSIGFMPQTGMGINPFFDAPYADVSKGIHISAYSYASMAKALLPIMNPGGSIVGMDFDPSRAMPAYNWMTVAKSALESVNRFVAREAGKYGVRSNLVAAGPIRTLAMSAIVGGALGEEAGAQIQLLEEGWDQRAPIGWNMKDATPVAKTVCALLSDWLPATTGDIIYADGGAHTQLL	91.82	gnl|BL_ORD_ID|1964|hsp_num:0	1574			387	600	isoniazid
